View our comprehensive portfolio of products for drug development and patient diagnosis and monitoring
Our products are trusted worldwide in research, clinical, and commercial laboratory settings.
Functional and biomarker assays for the exploration of every angle of the complement system
Our cell-based bioassays are based on iLite® technology – a cleverly designed cell-based assay system with reporter gene readouts
AAV Neutralizing Antibody (NAb), Total Antibody (TAb), and Complement Activation assays designed to provide a comprehensive view of vector immunogenicity
Solutions for detecting and semi-quantitating IgG antibodies against CCP
Our extensive CRO Services offer bioanalysis, biomarker discovery, and GMP QC testing.
With over 30 years of experience in autoimmune diagnostics, our ISO15189-certified specialist laboratory can help you reach the correct diagnosis. We also provide testing services and support for therapeutic drug monitoring.
Let us develop a custom iLite® cell line tailored to your needs.
Our cell services are highly reliable and innovative, tailored to your manufacturing needs
Scientific poster title: "Development of an iLite® Reporter Gene Cell Line for the Quantification of the Potency of Analogues of Human FGF21"
In this scientific poster, we showcase that normalization of drug-induced reporter gene activity, relative to the expression of an internal standardization gene under the control of a constitutive promoter, renders assay results independent of cell number and also provides a means for correcting for serum matrix effects and allows cytokine levels to be quantified even in sera with a relatively high level of cytotoxicity.
The iLite technology can be adapted for many applications throughout the drug development phases including drug manufacturing processes such as the quantification of vector potency and functionality or the detection of neutralizing anti-drug antibodies (NAb).